pfizer just laid out its mostdetailedyet explanation as to how the drug giant can still grow revenue in the coming years despite a 17 billion hit by 2030 through patent expirations pfizer stock ticker pfe has traded at a discount to peers for years over concerns about that socalled patent cliff despite the extraordinary sales bump the company received from its covid19 vaccine and antiviral